.
DBD financial statements
* Numbers in thousands
| Capitalization * | 560 272 |
|---|---|
| EV * | 2 586 680 |
| Number of shares * | 77 600 |
| EPS | -1,02 |
| Revenue * | 3 905 200 |
| Net income * | -78 800 |
| Operating profit * | 141 500 |
| Total liabilities * | 4 344 200 |
| Net debt * | 1 903 800 |
| Total assets * | 3 507 200 |
| Equity * | -845 100 |
| Cash and investments * | 423 200 |
.
DBD valuation
| P/E | -7,11 |
|---|---|
| P/B | -0,66 |
| P/S | 0,14 |
| E/P | -14 |
| P/FCF | 7,78 |
.
DBD profitability
| ROE | 9% |
|---|---|
| ROA% | -3% |
| ROIC% | 8% |